Kevin Charles Miller

16PUBLICATIONS
61CO-AUTHORS
Medical bacteriologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNot-for-profit finance and risk
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Feb 17, 2026
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

|Feb 09, 2026
First-line Therapy in Newly Diagnosed Multiple Myeloma.

Kevin C Miller, Saad Z Usmani

|May 02, 2025
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma.

Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand

|Apr 24, 2025
Recycling is "bad to the bone" in patients with myeloma.

Kevin C Miller, Alexander M Lesokhin

|Apr 08, 2025
Perspectives on Talquetamab and its Utility in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy.

Kevin C Miller, Issam Hamadeh, Carlyn Rose Tan

Pageof 3

Frequent Collaborators

5 joint publications

Alexander M Lesokhin

4 joint publications

Heather J Landau

4 joint publications

Sergio A Giralt

4 joint publications

Urvi A Shah